Comparison of two different protocols of neonatal screening for cystic fibrosis

被引:17
|
作者
Narzi, L
Lucarelli, M
Lelli, A
Grandoni, F
Lo Cicero, S
Ferraro, A
Matarazzo, P
Delaroche, I
Quattrucci, S
Strom, R
Antonelli, M
机构
[1] Univ Roma La Sapienza, Ctr Fibrosi Cistica Reg Lazio, Pediat Clin, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Sez Biochim Clin, Dipartimento Biotecnol Cellulari & Ematol, I-00161 Rome, Italy
关键词
cystic fibrosis; genetic testing; immunoreactive trypsin dosage; neonatal screening;
D O I
10.1034/j.1399-0004.2002.620311.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The results of two different protocols of neonatal cystic fibrosis (CF) screening in the Lazio region of Italy are reported. The first study, conducted from 1992 to 2000 on about 200,000 newborns, consisted of an immunoreactive trypsin (IRT) protocol without mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, referred to as the IRT/IRT protocol. Approximately 5% of the newborns with a positive first IRT test were also positive at the second test; approximately 57% of the newborns with a high IRT level at the second test were subsequently found to be affected by CF. In September 1998, a second protocol that included mutation analysis (IRT/DNA/IRT protocol) was started. Comparison of the two different screening protocols in terms of sensitivity in detecting CF patients demonstrated that the IRT/DNA/IRT protocol is more effective because it is able to detect a higher number of CF patients than the IRT/IRT protocol. In the same period, in addition to the overall diagnosis performed on a screening basis, 64 other subjects were identified as being affected by CF on the basis of symptomatic findings. The overall incidence of CF (screening + symptoms) was 1 : 2982, while that for carriers was 1 : 27. The sensitivity of the screening program increased over the period from 1992 to 2000, with the enhanced sensitivity in the past 2 years being due to the introduction of the IRT/DNA/IRT protocol.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 50 条
  • [1] Neonatal screening for cystic fibrosis
    不详
    [J]. JOURNAL OF MEDICAL SCREENING, 2001, 8 (01) : 51 - 51
  • [2] Neonatal screening for cystic fibrosis
    不详
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (05) : 449 - 449
  • [3] Neonatal screening for cystic fibrosis
    Tonks, A
    [J]. JOURNAL OF MEDICAL SCREENING, 2000, 7 (01) : 56 - 56
  • [4] Neonatal screening for cystic fibrosis
    Eichler, I
    Stöckler-Ipsiroglu, S
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2001, 149 (12) : 1311 - +
  • [5] Neonatal screening for cystic fibrosis
    Dudding, T
    Wilcken, B
    Burgess, B
    Turner, G
    [J]. LANCET, 2000, 356 (9245): : 1930 - 1930
  • [6] Neonatal screening for cystic fibrosis
    Gartner, S.
    Cobos, N.
    [J]. ANALES DE PEDIATRIA, 2009, 71 (06): : 481 - 482
  • [7] Neonatal screening for cystic fibrosis
    Wald, NJ
    Morris, JK
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7129): : 404 - 405
  • [8] APPLICATION OF DNA ANALYSIS IN A POPULATION-SCREENING PROGRAM FOR NEONATAL DIAGNOSIS OF CYSTIC-FIBROSIS (CF) - COMPARISON OF SCREENING PROTOCOLS
    GREGG, RG
    WILFOND, BS
    FARRELL, PM
    LAXOVA, A
    HASSEMER, D
    MISCHLER, EH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 52 (03) : 616 - 626
  • [9] NEONATAL SCREENING FOR CYSTIC-FIBROSIS
    DANKERTROELSE, JE
    TEMEERMAN, GJ
    CORNEL, MC
    KNOL, K
    TENKATE, LP
    [J]. LANCET, 1986, 1 (8484): : 802 - 803
  • [10] NEONATAL SCREENING FOR CYSTIC-FIBROSIS
    FARRIAUX, JP
    GILLY, R
    NAVARRO, J
    ROUSSEL, P
    TRAVERT, G
    [J]. ARCHIVES FRANCAISES DE PEDIATRIE, 1987, 44 (06): : 475 - 476